Cargando…
Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy
Autores principales: | Brunetti-Pierri, Nicola, Fecarotta, Simona, Staiano, Annamaria, Strisciuglio, Pietro, Parenti, Giancarlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629446/ https://www.ncbi.nlm.nih.gov/pubmed/32409735 http://dx.doi.org/10.1038/s41436-020-0831-4 |
Ejemplares similares
-
Ensuring continued progress for development of COVID-19 therapeutics in children
por: Noel, Gary J., et al.
Publicado: (2021) -
Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
por: Rossi, Alessandro, et al.
Publicado: (2021) -
Respiratory manifestations in patients with inherited metabolic diseases
por: Santamaria, Francesca, et al.
Publicado: (2013) -
New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
por: Fecarotta, Simona, et al.
Publicado: (2018) -
Ensuring global access to COVID-19 vaccines
por: Yamey, Gavin, et al.
Publicado: (2020)